Evaluation of the 8q24 Prostate Cancer Risk Locus and MYC Expression.

Departments of Medical Oncology and Biostatistics and Computational Biology, Dana-Farber Cancer Institute; and Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Division of Human Biology, Public Health Sciences Division, and Division of Clinical Research, Fred Hutchinson Cancer Research Center; Department of Urology, University of Washington; and Department of Veterans Affairs Puget Sound Health Care System, Seattle, Washington; Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, Maryland; Departments of Pathology and Laboratory Medicine, Clinical Neurosciences, and Oncology, University of Calgary, Calgary, Alberta, Canada; and Broad Institute of Harvard and MIT, Cambridge, Massachusetts. Polymorphisms at 8q24 are... [read full story]                    

powered by